Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Lung Therapeutics, Inc. See All Filings	D	2022-04-04 15:07:36 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Newbridge Securities Corporation CIK Number 0001611241 Filed Document 0001209191-22-022263 Exclusions or Exemptions 506b Accepted Date 2022-04-04 15:07:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D/A	2019-10-31 10:16:16 UTC
Amount To Be Raised $38,682,750 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-19-054587 Exclusions or Exemptions 506b Accepted Date 2019-10-31 10:16:16 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D	2019-05-24 13:35:18 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-19-032648 Exclusions or Exemptions 506b Accepted Date 2019-05-24 13:35:18 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D/A	2018-07-25 17:42:19 UTC
Amount To Be Raised $3,855,000 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-18-043929 Exclusions or Exemptions 506b Accepted Date 2018-07-25 17:42:19 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Lung Therapeutics, Inc. See All Filings	D	2018-06-18 10:04:32 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-18-038227 Exclusions or Exemptions 506b Accepted Date 2018-06-18 10:04:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Lung Therapeutics, Inc. See All Filings	D/A	2017-05-19 14:23:12 UTC
Amount To Be Raised $14,333,859 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-17-033871 Exclusions or Exemptions 506b Accepted Date 2017-05-19 14:23:12 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D/A	2017-02-24 12:01:42 UTC
Amount To Be Raised $17,000,000 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-17-014159 Exclusions or Exemptions 506b Accepted Date 2017-02-24 12:01:42 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D	2016-03-07 00:00:00 UTC
Amount To Be Raised $6,000,000 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-16-106855 Exclusions or Exemptions 506b Accepted Date 2016-03-07 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D/A	2015-09-30 00:00:00 UTC
Amount To Be Raised $2,568,912 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-15-072531 Exclusions or Exemptions 506b Accepted Date 2015-09-30 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Lung Therapeutics, Inc. See All Filings	D	2014-09-10 00:00:00 UTC
Amount To Be Raised $2,568,912 Associated Brokers / Dealers N/A CIK Number 0001611241 Filed Document 0001209191-14-057237 Exclusions or Exemptions 506b Accepted Date 2014-09-10 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity